BioSymposia
DC

Dr. Claire Beaumont

VP of Clinical Development

Novartis Oncology
Regulatory Affairs

Biography

Dr. Beaumont has overseen regulatory submissions for three approved checkpoint inhibitors and advises the FDA on cell therapy policy.

Speaking At (1 event)

Summit

Global Summit on Immunotherapy & Cancer Biology

July 15 – 16, 2026Chicago, United States

Speaker Stats

Events1
InstitutionNovartis Oncology
SpecialtyRegulatory Affairs